Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes

Mohammed A. Matlib, Zhuan Zhou, Selena Knight, Saadia Ahmed, Kin M. Choi, Jeanette Krause-Bauer, Ronald Phillips, Ruth Altschuld, Yasuhiro Katsube, Nicholas Sperelakis, Donald M Bers

Research output: Contribution to journalArticle

209 Citations (Scopus)

Abstract

Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J., Clarke, M. J, Ying, W-L., and Sanadi, D. R. (1993) J. AM. Chem. Soc. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+- stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes. Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria. 103Ru360 was found to bind to isolated mitochondria with high affinity (K(d) = 0.34 nM, B(max) = 80 fmol/mg of mitochondrial protein). The IC50 of 103Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 μM, produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L- type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. 103Ru360 was taken up by isolated myocytes in a time-dependent bipbasic manner. Ru360 (10 μM) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.

Original languageEnglish (US)
Pages (from-to)10223-10231
Number of pages9
JournalJournal of Biological Chemistry
Volume273
Issue number17
DOIs
StatePublished - Apr 24 1998
Externally publishedYes

Fingerprint

Mitochondria
Ruthenium
Cardiac Myocytes
Amines
Oxygen
Inhibitory Concentration 50
Ruthenium Red
Sarcoplasmic Reticulum
Muscle Cells
In Vitro Techniques
Ru 360
Liver Mitochondrion
Mitochondrial Proteins
Myosins
Depolarization
Liver
Respiration
Binding Sites
Derivatives

ASJC Scopus subject areas

  • Biochemistry

Cite this

Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. / Matlib, Mohammed A.; Zhou, Zhuan; Knight, Selena; Ahmed, Saadia; Choi, Kin M.; Krause-Bauer, Jeanette; Phillips, Ronald; Altschuld, Ruth; Katsube, Yasuhiro; Sperelakis, Nicholas; Bers, Donald M.

In: Journal of Biological Chemistry, Vol. 273, No. 17, 24.04.1998, p. 10223-10231.

Research output: Contribution to journalArticle

Matlib, MA, Zhou, Z, Knight, S, Ahmed, S, Choi, KM, Krause-Bauer, J, Phillips, R, Altschuld, R, Katsube, Y, Sperelakis, N & Bers, DM 1998, 'Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes', Journal of Biological Chemistry, vol. 273, no. 17, pp. 10223-10231. https://doi.org/10.1074/jbc.273.17.10223
Matlib, Mohammed A. ; Zhou, Zhuan ; Knight, Selena ; Ahmed, Saadia ; Choi, Kin M. ; Krause-Bauer, Jeanette ; Phillips, Ronald ; Altschuld, Ruth ; Katsube, Yasuhiro ; Sperelakis, Nicholas ; Bers, Donald M. / Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. In: Journal of Biological Chemistry. 1998 ; Vol. 273, No. 17. pp. 10223-10231.
@article{eb5c4d9b8b3f4903b6502c779057f601,
title = "Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes",
abstract = "Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J., Clarke, M. J, Ying, W-L., and Sanadi, D. R. (1993) J. AM. Chem. Soc. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+- stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes. Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria. 103Ru360 was found to bind to isolated mitochondria with high affinity (K(d) = 0.34 nM, B(max) = 80 fmol/mg of mitochondrial protein). The IC50 of 103Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 μM, produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L- type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. 103Ru360 was taken up by isolated myocytes in a time-dependent bipbasic manner. Ru360 (10 μM) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.",
author = "Matlib, {Mohammed A.} and Zhuan Zhou and Selena Knight and Saadia Ahmed and Choi, {Kin M.} and Jeanette Krause-Bauer and Ronald Phillips and Ruth Altschuld and Yasuhiro Katsube and Nicholas Sperelakis and Bers, {Donald M}",
year = "1998",
month = "4",
day = "24",
doi = "10.1074/jbc.273.17.10223",
language = "English (US)",
volume = "273",
pages = "10223--10231",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "17",

}

TY - JOUR

T1 - Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes

AU - Matlib, Mohammed A.

AU - Zhou, Zhuan

AU - Knight, Selena

AU - Ahmed, Saadia

AU - Choi, Kin M.

AU - Krause-Bauer, Jeanette

AU - Phillips, Ronald

AU - Altschuld, Ruth

AU - Katsube, Yasuhiro

AU - Sperelakis, Nicholas

AU - Bers, Donald M

PY - 1998/4/24

Y1 - 1998/4/24

N2 - Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J., Clarke, M. J, Ying, W-L., and Sanadi, D. R. (1993) J. AM. Chem. Soc. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+- stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes. Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria. 103Ru360 was found to bind to isolated mitochondria with high affinity (K(d) = 0.34 nM, B(max) = 80 fmol/mg of mitochondrial protein). The IC50 of 103Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 μM, produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L- type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. 103Ru360 was taken up by isolated myocytes in a time-dependent bipbasic manner. Ru360 (10 μM) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.

AB - Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J., Clarke, M. J, Ying, W-L., and Sanadi, D. R. (1993) J. AM. Chem. Soc. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+- stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes. Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria. 103Ru360 was found to bind to isolated mitochondria with high affinity (K(d) = 0.34 nM, B(max) = 80 fmol/mg of mitochondrial protein). The IC50 of 103Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 μM, produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L- type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. 103Ru360 was taken up by isolated myocytes in a time-dependent bipbasic manner. Ru360 (10 μM) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.

UR - http://www.scopus.com/inward/record.url?scp=0032562816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032562816&partnerID=8YFLogxK

U2 - 10.1074/jbc.273.17.10223

DO - 10.1074/jbc.273.17.10223

M3 - Article

VL - 273

SP - 10223

EP - 10231

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 17

ER -